Skip to main content
Year archive

4SC AG — 2011 filings

All 60 regulatory filings released by 4SC AG (VSC) in 2011, sourced directly from the official regulator.

60 Filings
2011 Period
2011 filings (60)
Filing Released Lang
Press Release: 4SC forms subsidiary to commercialise innovative early-stage drug research
Regulatory Filings
2011-12-14 English
4SC forms subsidiary to commercialise innovative early-stage drug research
Regulatory Filings
2011-12-14 English
Press Release: 4SC Obtains Key Patent for Lead Anti-Cancer Compound
Regulatory Filings
2011-12-07 English
Press Release: 4SC to present at World Epigenetics Summit clinical development programme with lead cancer drug Resminostat
Regulatory Filings
2011-12-06 English
4SC to present results of clinical Phase II study with Resminostat in Hodgkin's Lymphoma at ASH Meeting in San Diego
Regulatory Filings
2011-12-05 English
Q3 Report 2011
Interim / Quarterly Report 9M 2011
2011-11-09 English
4SC announces financial results for the third quarter and first nine months of 2011
Earnings Release 9M 2011
2011-11-08 English
4SC presents encouraging final results of Vidofludimus Phase IIb COMPONENT study in Rheumatoid Arthritis at ACR Meeting in Chicago
Earnings Release FY 2011
2011-11-07 English
4SC to Host Conference Call on 8 November, 2011 to Present Q3 and first Nine Months 2011 Financial Results
Regulatory Filings
2011-11-02 English
4SC's anti-cancer compound Resminostat receives positive opinion for orphan medicinal product designation in Europe to treat Hodgkin's Lymphoma
Environmental & Social Information
2011-10-13 English
4SC's Resminostat receives FDA Orphan Drug Status for Hodgkin's Lymphoma
Regulatory Filings
2011-09-26 English
4SC to Present at the Jefferies 2011 Global Healthcare Conference in London
Regulatory Filings
2011-09-21 English
4SC's Resminostat Meets Primary Efficacy Endpoint in Phase II Trial in Hodgkin's Lymphoma (HL)
Earnings Release Q3 2011
2011-09-06 English
4SC's Resminostat Meets Primary Efficacy Endpoint in Phase II Trial in Hodgkin's Lymphoma (HL)
Regulatory Filings
2011-09-06 English
DGAP-DD: 4SC AG english
Director's Dealing
2011-08-18 English
4SC announces financial results for the second quarter and first half of 2011
Earnings Release H1 2011
2011-08-09 English
Q2 Report 2011
Interim / Quarterly Report H1 2011
2011-08-09 English
4SC to Host Conference Call and Webcast on 9 August, 2011 to Discuss Q2 and HY 2011 Financial Results
Report Publication Announcement
2011-08-02 English
European Medicines Agency Adopts Positive Opinion for Orphan Medicinal Product Designation for 4SC's Resminostat to Treat Hepatocellular Carcinoma
Regulatory Filings
2011-07-26 English
FDA grants Orphan Drug Designation to 4SC's Oral Pan-HDAC Inhibitor Resminostat for the Treatment of Hepatocellular Carcinoma
Regulatory Filings
2011-07-12 English
4SC Reports New Data from the Clinical Trials with Oral Pan-HDAC Inhibitor Resminostat
Regulatory Filings
2011-06-23 English
Veroffentlichung gema 26a Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung
Declaration of Voting Results & Voting Rights Announcements
2011-06-16 German
Release according to Article 26a of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements
2011-06-14 English
4SC Announces Topline Results of Phase IIb Trial of Vidofludimus in Rheumatoid Arthritis
Regulatory Filings
2011-06-08 English
4SC Announces Topline Results of Phase IIb Trial of Vidofludimus in Rheumatoid Arthritis
Regulatory Filings
2011-06-08 English
4SC to Present at the Jefferies 2011 Global Healthcare Conference
Regulatory Filings
2011-05-30 English
EULAR 2011 - Vidofludimus Superior to Cyclophosphamide and MMF in an Experimental Systemic Lupus Erythematosus Model
Regulatory Filings
2011-05-27 English
4 SC AG: Bekanntmachung der Einberufung zur Hauptversammlung am 04.07.2011 in Munchen mit dem Ziel der europaweiten Verbreitung gema 121 AktG
AGM Information
2011-05-25 German
Jahresabschluss zum Geschäftsjahr vom 01.01.2010 bis zum 31.12.2010
Annual Report FY 2010
2011-05-16 German
4SC Announces Financial Results for the First Quarter 2011
Earnings Release Q1 2011
2011-05-10 English
Q1 Report 2011
Interim / Quarterly Report Q1 2011
2011-05-10 English
4SC's Vidofludimus Inhibits IL-17 Production by Interference With the JAK/STAT and NF-kB Pathways
Environmental & Social Information
2011-05-09 English
4SC AG: Q1 2011 Results Conference Call 10 May, 2011
Report Publication Announcement
2011-05-03 English
Declaration of Voting Results & Voting Rights Announcements 2011
Declaration of Voting Results & Voting Rights Announcements
2011-04-27 German
Declaration of Voting Results & Voting Rights Announcements 2011
Declaration of Voting Results & Voting Rights Announcements
2011-04-27 German
Declaration of Voting Results & Voting Rights Announcements 2011
Declaration of Voting Results & Voting Rights Announcements
2011-04-27 German
Declaration of Voting Results & Voting Rights Announcements 2011
Declaration of Voting Results & Voting Rights Announcements
2011-04-27 German
Declaration of Voting Results & Voting Rights Announcements 2011
Declaration of Voting Results & Voting Rights Announcements
2011-04-27 German
4SC and Yakult Honsha Announce Exclusive License Agreement for Japan for the Oral HDAC Inhibitor Resminostat
Legal Proceedings Report
2011-04-14 English
4SC Announces Exclusive License Agreement for Japan with Yakult Honsha for the Oral HDAC Inhibitor Resminostat
Regulatory Filings
2011-04-14 English
4SC Announces Treatment of First Patient in Phase I TOPAS Study with the selective HDAC inhibitor 4SC-202
Regulatory Filings
2011-04-13 English
4SC Announces Financial Results 2010
Earnings Release FY 2010
2011-03-29 English
Annual Report 2010
Annual Report FY 2010
2011-03-29 English
Annual Report 2010
Annual Report FY 2010
2011-03-29 German
4SC Full Year Results - Conference Call and Webcast, 29 March, 2011
Earnings Release FY 2010
2011-03-22 English
Declaration of Voting Results & Voting Rights Announcements 2011
Declaration of Voting Results & Voting Rights Announcements
2011-03-17 English
Declaration of Voting Results & Voting Rights Announcements 2011
Declaration of Voting Results & Voting Rights Announcements
2011-03-10 German
Declaration of Voting Results & Voting Rights Announcements 2011
Declaration of Voting Results & Voting Rights Announcements
2011-03-10 German
Declaration of Voting Results & Voting Rights Announcements 2011
Declaration of Voting Results & Voting Rights Announcements
2011-03-09 German
Declaration of Voting Results & Voting Rights Announcements 2011
Declaration of Voting Results & Voting Rights Announcements
2011-03-09 German
Release according to Article 26a of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements
2011-03-01 English
4SC Presents Final Phase IIa Data on Vidofludimus in Inflammatory Bowel Disease Study at the 6th ECCO IBD Conference
Earnings Release Q1 2011
2011-02-28 English
4SC Completes Capital Increase
Share Issue/Capital Change
2011-02-24 English
4SC Announces Capital Increase
Share Issue/Capital Change
2011-02-23 English
Report Publication Announcement 2011
Report Publication Announcement
2011-02-07 English
Hinweis auf Quartalsfinanzbericht
Report Publication Announcement
2011-02-07 German
Datum:07.02.2011
Report Publication Announcement
2011-02-07 German
4SC Presents Update on Phase II SHELTER trial with Oral Pan-HDAC Resminostat at the 2011 Gastrointestinal Cancer Symposium
Regulatory Filings
2011-01-21 English
4SC Announces First Patient Dosed in Phase I/II SHORE Study in KRAS-Mutant Colorectal Cancer Patients with Resminostat
Legal Proceedings Report
2011-01-20 English
4SC Announces First-in-Man Phase I Results for 4SC-203
Regulatory Filings
2011-01-07 English